Fresh, equilibrated and post-thaw sperm quality of Brycon orbignyanus (Valenciennes, 1850) and Prochilodus lineatus (Valenciennes, 1837) treated with either salmon GnRHa and domperidone or pituitary extract

The effects of reduced doses of Ovaprim™ (GnRHa + domperidone) on sperm release of Brycon orbignyanus and Prochilodus lineatus were evaluated. Furthermore, sperm quality was compared among fresh, equilibrated and post-thaw samples. Males received a single and reduced dose of Ovaprim™ (0.125 or 0.25 ml/kg); control males received pituitary extract (cPE; 3 mg/kg). Fresh sperm was evaluated for volume, concentration, seminal plasma osmolality and seminal plasma pH. Then sperm was diluted in a freezing medium, equilibrated for 15-20 min and frozen in nitrogen vapor vessel (dry-shipper). Sperm motility was analyzed during 60 s post-activation in fresh, equilibrated and post-thaw samples. Sperm quality of males treated with Ovaprim™ (both doses) were not different from that of cPE-treated males, thus these data were pooled. In B. orbignyanus, motility was higher in fresh (99%) than in equilibrated sperm (81%); post-thaw motility dropped to 42%. In P. lineatus, motility was similar in fresh (99%) and equilibrated sperm (92%); post-thaw motility was 73%. Motility decreased as a function of time post-activation, and this decrease was significant after 60 s in fresh and equilibrated sperm, and as soon as 30 s in post-thaw sperm, in both species. Ovaprim™ at 1/4 of the recommended dose can successfully replace cPE.

O efeito de doses reduzidas de Ovaprim® (GnRHa + domperidona) na liberação do sêmen de Brycon orbignyanus e Prochilodus lineatus foi avaliado. Além disso, a qualidade do sêmen foi comparada entre as amostras frescas, equilibradas e descongeladas. Os machos receberam dose única e reduzida de Ovaprim® (0,125 ou 0,25 ml/kg); os machos-controle receberam extrato de hipófise (cPE; 3 mg/kg). O sêmen fresco foi avaliado quanto ao volume, concentração, e osmolalidade e pH do plasma seminal. Em seguida, o sêmen foi diluído num meio de congelamento, equilibrado por 15-20 min e congelado em botijão de vapor de nitrogênio (dry-shipper). A motilidade espermática foi analisada durante 60 s pós-ativação no sêmen fresco, equilibrado e descongelado. A qualidade do sêmen não diferiu entre os machos tratados com Ovaprim® (ambas as doses) ou cPE, assim foi feito um pool desses dados. Em B. orbignyanus, a motilidade foi maior no sêmen fresco (99%) do que no equilibrado (81%); a motilidade do sêmen descongelado caiu para 42%. Em P. lineatus, a motilidade foi semelhante entre o sêmen fresco (99%) e equilibrado (92%); a motilidade do sêmen descongelado foi 73%. A motilidade caiu em função do tempo pós-ativação, e essa queda foi significante após 60 s no sêmen fresco e equilibrado, e tão precoce quanto 30 s no sêmen descongelado, em ambas as espécies. Ovaprim® a 1/4 da dose recomendada pode substituir o cPE com sucesso.

Efectos del extracto hipofisiario de carpa común y el análogo de la GnRH sobre la maduración final del oocito y el desove de la cachama negra (Colossoma macropomum) / Effects of hypophysial extract of common carp and the analog of the GnRH on the final maturation oocyte and the spawning of cachama negra (Colossoma macropomum)

El objetivo principal de este estudio fue comparar el uso de un análogo de la sGnRH (Ovaprim®) con el extracto de hipófisis de carpa (EHC) en la reproducción inducida de Colossoma macropomum. Se evaluaron dos tratamientos, uno con Ovaprim® (0,5 mL/kg) y otro con EHC (5 mg/kg) y un tercer grupo fue el control. El desempeño reproductivo fue evaluado en machos, mediante la producción y concentración de esperma; en las hembras, a través del porcentaje de ovulación, fecundidad absoluta, fecundidad relativa, tasa de fecundación y tasa de eclosión. El Ovaprim® tuvo un efecto similar al EHC en la producción y concentración del semen de los machos inyectados. En las hembras, el porcentaje de ovulación fue similar (100 por ciento) en ambos tratamientos. Se encontraron diferencias significativas (P<0,05) en el número de óvulos producidos con Ovaprim® (155,6 x10³) y EHC (67,5 x 10³). Las mejores tasas de fecundación y eclosión se obtuvieron en el grupo tratado con EHC (63,26 y 68,48 por ciento) que con Ovaprim® (11,12 y 19,75 por ciento, respectivamente). Estos resultados indican que el tratamiento con Ovaprim® es efectivo para inducir el desove, pero produce óvulos de baja calidad.

The primary target of this study was to compare the use of an analog of sGnRH (Ovaprim®) with the carp pituitary extract (CPE) in the induced reproduction of Colossoma macropomum. Three treatments, one control, one with Ovaprim® (0.5 mL/kg) and one with CPE were evaluated (5mg/kg). The reproductive performance was evaluated in males, by means of the production and concentration of sperm, in the females, spawning ratio, absolute fecundity, relative fecundity, rate of fertilization and hatching. The Ovaprim® had an effect similar to the CPE in the production and concentration of semen of the injected males. The spawning ratio was similar (100 percent) in both treatments. A statistically significant (P<0.05) difference between the number of eggs obtained with Ovaprim® (155.6 x10³) and CPE (67.5 x10³). The best rates of fertilization and hatching were obtained in the group treated with CPE (63.26 and 68.48 percent) that with Ovaprim® (11.12 and 19.75 percent), respectively. These results indicate that the treatment with Ovaprim® is effective to induce the spawning, but produces eggs of low quality.